Genzyme Sues Lupin Over Generic Renagel
Biotechnology company Genzyme Corp. has sued Lupin Pharmaceuticals Inc. to prevent it from marketing a generic version of Renagel, a drug used to treat serum phosphorus in chronic kidney disease patients...To view the full article, register now.
Already a subscriber? Click here to view full article